-
1
-
-
0036186078
-
Pathology of lung cancer
-
Travis WD. Pathology of lung cancer. Clin Chest Med 2002;23:65-81.
-
(2002)
Clin Chest Med
, vol.23
, pp. 65-81
-
-
Travis, W.D.1
-
2
-
-
49049109683
-
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
-
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-9.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3552-3559
-
-
Pignon, J.P.1
Tribodet, H.2
Scagliotti, G.V.3
Douillard, J.Y.4
Shepherd, F.A.5
Stephens, R.J.6
-
3
-
-
84861980920
-
Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: in vitro analysis based on the collagen droplet embedded culture drug test (CD-DST)
-
Higashiyama M, Okami J, Maeda J, Tokunaga T, Fujiwara A, Kodama K, et al. Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: in vitro analysis based on the collagen droplet embedded culture drug test (CD-DST). J Thoracic Dis 2011;4:40-7.
-
(2011)
J Thoracic Dis
, vol.4
, pp. 40-47
-
-
Higashiyama, M.1
Okami, J.2
Maeda, J.3
Tokunaga, T.4
Fujiwara, A.5
Kodama, K.6
-
4
-
-
77649178137
-
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy
-
Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010;16:1442-51.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1442-1451
-
-
Dong, X.1
Guan, J.2
English, J.C.3
Flint, J.4
Yee, J.5
Evans, K.6
-
5
-
-
73349134974
-
Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities
-
Toole BP. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009;15:7462-8.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 7462-7468
-
-
Toole, B.P.1
-
6
-
-
0036606299
-
Molecular profiling of non-small cell lung cancer and correlation with disease-free survival
-
Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, Liu N. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 2002;62:3005-8.
-
(2002)
Cancer Res
, vol.62
, pp. 3005-3008
-
-
Wigle, D.A.1
Jurisica, I.2
Radulovich, N.3
Pintilie, M.4
Rossant, J.5
Liu, N.6
-
7
-
-
77958072139
-
The tissue is the issue: personalized medicine for non-small cell lung cancer
-
Hirsch FR, Wynes MW, Gandara DR, Bunn Jr PA. The tissue is the issue: personalized medicine for non-small cell lung cancer. Clin Cancer Res 2010;16:4909-11.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4909-4911
-
-
Hirsch, F.R.1
Wynes, M.W.2
Gandara, D.R.3
Bunn Jr., P.A.4
-
8
-
-
62249112106
-
Personalized cancer therapy gets closer
-
Hayden EC. Personalized cancer therapy gets closer. Nature 2009;458:131-2.
-
(2009)
Nature
, vol.458
, pp. 131-132
-
-
Hayden, E.C.1
-
9
-
-
79953158399
-
Exploring the genomes of cancer cells: progress and promise
-
Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011;331:1553-8.
-
(2011)
Science
, vol.331
, pp. 1553-1558
-
-
Stratton, M.R.1
-
10
-
-
79551511484
-
Genomic medicine in non-small cell lung cancer: Paving the path to personalized care
-
Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Genomic medicine in non-small cell lung cancer: Paving the path to personalized care. Respirology 2011;16:257-63.
-
(2011)
Respirology
, vol.16
, pp. 257-263
-
-
Sriram, K.B.1
Larsen, J.E.2
Yang, I.A.3
Bowman, R.V.4
Fong, K.M.5
|